Also trades as: 5EA.DE (XETRA) · $vol 0M
ELAN NYSE
Elanco Animal Health Incorporated
1W: -0.3%
1M: +0.8%
3M: -14.2%
YTD: +0.5%
1Y: +2.7%
3Y: +147.2%
5Y: -30.6%
$22.65
-0.31 (-1.35%)
Weekly Expected Move ±3.8%
$21
$22
$23
$23
$24
Credit Risk of going bust: lower than 51% of companies Debt: 25.7% of company value Bonds: $41.9M held by 70 funds, 126 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.65 (down 97%), Elanco Animal Health Incorporated would be worth roughly what it owes.
Total debt $3.92B against a stock market value of $11.31B.
Distance to default 5.20 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.00B (short-term plus half of long-term), stock volatility 42.0%; Altman Z 1.32. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.65 (down 97%), Elanco Animal Health Incorporated would be worth roughly what it owes.
Total debt $3.92B against a stock market value of $11.31B.
Distance to default 5.20 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.00B (short-term plus half of long-term), stock volatility 42.0%; Altman Z 1.32. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships8
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-06-16
Earliest Filing
2024-07-09
Latest Filing
acquirer: 5
target: 2
investor: 1
Counterparties (Filed by ELAN)
8 relationshipsCompanies named in ELAN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Intervet International B.V. | INTR | acquirer | Acquired Elanco's aqua business assets for approximately $1.3 billion in cash. | 2024-07-09 | View |
| Ancora Catalyst Institutional, LP | — | investor | Entered into a cooperation agreement with the Company to appoint directors and establish standstill restrictions. | 2024-04-01 | View |
| Intervet International B.V. | INTR | acquirer | Acquired Elanco's aqua business assets for approximately $1.3 billion. | 2024-02-05 | View |
| Elanco Animal Health Incorporated | ELAN | acquirer | Acquiring Kindred Biosciences, Inc. in a merger transaction | 2021-07-01 | View |
| Kindred Biosciences, Inc. | KRED | target | Target company being acquired by Elanco Animal Health Incorporated | 2021-07-01 | View |
| Elanco Animal Health Incorporated | ELAN | acquirer | Acquiring company entering into a merger agreement. | 2021-06-16 | View |
| Knight Merger Sub, Inc. | — | acquirer | Wholly owned subsidiary of Elanco used as the merger vehicle. | 2021-06-16 | View |
| Kindred Biosciences, Inc. | KRED | target | Target company being acquired in the merger. | 2021-06-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-05-27 | Shareholder Vote | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-02-24 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-09 | Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure; Financial Statements an | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-03 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-26 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-05-28 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-05-21 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-17 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-11-12 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-16 | Regulation FD Disclosure | View | |
| 2024-08-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR